//
Guideline‐Directed Medical Therapy for Patients With Heart Failure With Midrange Ejection Fraction: A Patient‐Pooled Analysis From the KorHF and KorAHF Registries
The year in cardiology: heart failure: The year in cardiology 2019
When and how to use SGLT2 inhibitors in patients with HFrEF or chronic kidney disease
Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators
Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure
Sex- and Race-Related Differences in Characteristics and Outcomes of Hospitalizations for Heart Failure With Preserved Ejection Fraction
The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5)
Dapagliflozin for treating chronic heart failure with reduced ejection fraction